Malibu Boats Reports Q4 and FY2026 Results; Details Pending

What happened

Malibu Boats announced its fourth quarter and full year fiscal 2026 results on August 27, 2026, but the press release does not include specific financial figures. The company had previously guided for flat to down mid-single-digit net sales and 8-9% Adjusted EBITDA margin for FY26, with Q1 FY26 actuals showing revenue growth but a 6.1% margin. The latest DeepValue master report, based on data through January 2026, rated MBUU a WAIT with an attractive entry near $27 and a trim level above $40, while the stock traded around $33. This announcement serves as the formal release of results that will be compared against those expectations, but without the numbers, no immediate conclusion can be drawn. Investors will need to review the full earnings release and management commentary to assess whether the company met, missed, or exceeded its guidance and how the outlook for fiscal 2027 may shift.

Implication

The announcement provides no new information beyond confirming that fiscal year 2026 results have been released. Based on prior guidance and industry data, Malibu likely saw revenue near flat and Adjusted EBITDA margin in the high single digits, in line with its conservative outlook. The stock's reaction will hinge on whether actual results beat or miss the guidance and on management's forward-looking statements for fiscal 2027, particularly regarding dealer inventories, tariffs, and interest rates. Until then, the investment thesis remains unchanged: downside protection is limited at current prices, and upside requires clear signs of margin recovery and volume stabilization. Pullbacks toward the high $20s would offer a better risk/reward, while rallies above $40 should be trimmed.

Thesis delta

The thesis delta is negligible; the press release merely announces the results without providing numbers. The WAIT rating and valuation range (entry $27, trim $40) remain valid. A shift would occur if actual FY26 results materially deviate from the 8-9% Adjusted EBITDA margin and flat sales guidance, or if management's FY27 outlook signals a faster or slower recovery.